 NEW YORK, Dec. 06, 2022 GLOBE NEWSWIRE -- Tiziana Life Sciences Ltd. Nasdaq: TLSA Tiziana or the Company, a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, today announced that the 2022 Annual General Meeting of the Company will be held on December 29, 2022. The record date for voting at the Annual General Meeting is set as November 30, 2022. The notice, agenda and associated material have been despatched to shareholders via mail and the notice, agenda and related financial statements in the form of the relevant Form 20-F filing are available on the Companys website at and respectively. 